Application of Radiomics and Artificial Intelligence for Lung Cancer Precision Medicine
- 11 January 2021
- journal article
- research article
- Published by Cold Spring Harbor Laboratory in Cold Spring Harbor Perspectives in Medicine
- Vol. 11 (8), a039537
- https://doi.org/10.1101/cshperspect.a039537
Abstract
Medical imaging is the standard-of-care for early detection, diagnosis, treatment planning, monitoring, and image-guided interventions of lung cancer patients. Most medical images are stored digitally in a standardized Digital Imaging and Communications in Medicine format that can be readily accessed and used for qualitative and quantitative analysis. Over the several last decades, medical images have been shown to contain complementary and interchangeable data orthogonal to other sources such as pathology, hematology, genomics, and/or proteomics. As such, “radiomics” has emerged as a field of research that involves the process of converting standard-of-care images into quantitative image-based data that can be merged with other data sources and subsequently analyzed using conventional biostatistics or artificial intelligence (AI) methods. As radiomic features capture biological and pathophysiological information, these quantitative radiomic features have shown to provide rapid and accurate noninvasive biomarkers for lung cancer risk prediction, diagnostics, prognosis, treatment response monitoring, and tumor biology. In this review, radiomics and emerging AI methods in lung cancer research are highlighted and discussed including advantages, challenges, and pitfalls.Keywords
This publication has 94 references indexed in Scilit:
- The 7th lung cancer TNM classification and staging system: Review of the changes and implicationsWorld Journal of Radiology, 2012
- Reduced Lung-Cancer Mortality with Low-Dose Computed Tomographic ScreeningThe New England Journal of Medicine, 2011
- New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)European Journal of Cancer, 2009
- Performance analysis of a new computer aided detection system for identifying lung nodules on chest radiographsMedical Image Analysis, 2008
- Prognostic factors in non-small cell lung cancer surgeryEuropean Journal of Surgical Oncology, 2006
- Clinical Course of Patients with Non–Small Cell Lung Cancer and Epidermal Growth Factor Receptor Exon 19 and Exon 21 Mutations Treated with Gefitinib or ErlotinibClinical Cancer Research, 2006
- Erlotinib in Previously Treated Non–Small-Cell Lung CancerThe New England Journal of Medicine, 2005
- Classification of malignant and benign masses based on hybrid ART2LDA approachIEEE Transactions on Medical Imaging, 1999
- Quantitative surface characterization of pulmonary nodules based on thin-section CT imagesIEEE Transactions on Nuclear Science, 1998
- An approach to automated detection of tumors in mammogramsIEEE Transactions on Medical Imaging, 1990